ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Leaks From Cooperative Group Site Visits Vex CCIRC; Tumor Cell Cloning Workshop Set

August 11, 1978

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988